These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1080432)

  • 1. Chemical synthesis of a peptide fragment of thymopoietin II that induces selective T cell differentiation.
    Schlesinger DH; Goldstein G; Scheid MP; Boyse EA
    Cell; 1975 Aug; 5(4):367-70. PubMed ID: 1080432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The amino acid sequence of thymopoietin II.
    Schlesinger DH; Goldstein G
    Cell; 1975 Aug; 5(4):361-5. PubMed ID: 1171728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymopoietin and myasthenia gravis: neostigmine-responsive neuromuscular block produced in mice by a synthetic peptide fragment of thymopoietin.
    Goldstein G; Schlesinger DH
    Lancet; 1975 Aug; 2(7928):256-9. PubMed ID: 49801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrasting biological activities of thymopoietin and splenin, two closely related polypeptide products of thymus and spleen.
    Audhya T; Scheid MP; Goldstein G
    Proc Natl Acad Sci U S A; 1984 May; 81(9):2847-9. PubMed ID: 6585832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural requirements for the biological activity of thymopentin analogs.
    Heavner GA; Audhya T; Kroon D; Goldstein G
    Arch Biochem Biophys; 1985 Oct; 242(1):248-55. PubMed ID: 2996431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooperativity of thymopoietin 32-36 (the active site) and thymopoietin 38-45 in receptor binding.
    Audhya T; Heavner GA; Kroon DJ; Goldstein G
    Regul Pept; 1984 Oct; 9(3):155-64. PubMed ID: 6098937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syntheses and effects of [Glu34]-thymopoietin II fragment 32-45 and its analogs on the impaired T-cell transformation in a patient with common variable immunodeficiency.
    Abiko T; Shishido H; Sekino H
    Biotechnol Appl Biochem; 1986; 8(2-3):160-71. PubMed ID: 3488750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and complete amino acid sequence of human thymopoietin and splenin.
    Audhya T; Schlesinger DH; Goldstein G
    Proc Natl Acad Sci U S A; 1987 Jun; 84(11):3545-9. PubMed ID: 3473468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A synthetic pentapeptide with biological activity characteristic of the thymic hormone thymopoietin.
    Goldstein G; Scheid MP; Boyse EA; Schlesinger DH; Van Wauwe J
    Science; 1979 Jun; 204(4399):1309-10. PubMed ID: 451537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid-phase synthesis of thymosin beta 4: chemical and biological characterization of the synthetic peptide.
    Low TL; Wang SS; Goldstein AL
    Biochemistry; 1983 Feb; 22(4):733-40. PubMed ID: 6838821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymopoietin, ubiquitin and the differentiation of lymphocytes.
    Hadden JW
    Clin Bull; 1975; 5(2):66-7. PubMed ID: 1084233
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunological status of patients with recurrent herpes simplex infections. In vitro effect of thymopoietin and splenin-derived and partially modified peptides on peripheral blood lymphocytes in comparison to a thymus extract].
    Simon HU; Roth H; Forner K; Haroske D
    Allerg Immunol (Leipz); 1990; 36(2):111-8. PubMed ID: 1975471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical synthesis and application of C-terminally 5-carboxyfluorescein-labelled thymopentin as a fluorescent probe for thymopoietin receptor.
    Onoue S; Liu B; Nemoto Y; Hirose M; Yajima T
    Anal Sci; 2006 Dec; 22(12):1531-5. PubMed ID: 17159311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymus-repopulating capacity of cells that can be induced to differentiate to T cells in vitro.
    Komure K; Goldstein G; Boyse EA
    J Immunol; 1975 Jul; 115(1):195-8. PubMed ID: 50347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of deacetyl-thymosin beta 12 and examination of its immunological effects on the impaired T and B lymphocytes in uremic patients.
    Abiko T; Sekino H
    Biotechnol Ther; 1993; 4(3-4):221-37. PubMed ID: 8292971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioassay determinations of thymopoietin and thymic hormone levels in human plasma.
    Twomey JJ; Goldstein G; Lewis VM; Bealmear PM; Good RA
    Proc Natl Acad Sci U S A; 1977 Jun; 74(6):2541-5. PubMed ID: 302007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syntheses and effects of human splenin (hSP) fragment 32-48 and an analog on the reduced B-lymphocytes of uremic patients.
    Abiko T; Sekino H
    Chem Pharm Bull (Tokyo); 1989 Sep; 37(9):2472-6. PubMed ID: 2605694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The isolation of thymopoietin (thymin).
    Goldstein G
    Ann N Y Acad Sci; 1975 Feb; 249():177-85. PubMed ID: 165765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of substances with thymosin-like activity by B- and T-lymphocytes.
    Nikolsky IS; Seleznyova TN; Zamotayeva GA; Martynenko SV; Grinevich YuA
    J Hyg Epidemiol Microbiol Immunol; 1990; 34(3):309-14. PubMed ID: 2273248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syntheses and effects of a thymopoietin II fragment and its analogs on the impaired T-cell transformation in a patient with common variable immunodeficiency.
    Abiko T; Shishido H; Sekino H
    J Appl Biochem; 1985 Dec; 7(6):408-22. PubMed ID: 3879489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.